Mozart Therapeutics
Nadine Morgan, PhD, is an accomplished immunologist currently serving as an Associate Scientist at Mozart Therapeutics, Inc. since May 2022. Previously, Nadine completed a PhD in Immunology at the University of Alabama at Birmingham, where from August 2014 to April 2022, extensive research was conducted on immunology assays, focusing on antigen-specific cells in inflammatory bowel disease. Earlier research experience includes roles as a Graduate Research Assistant at Loyola University Chicago, exploring T cell biology, and as an NIH Post-Baccalaureate Research Scholar at Wright State University, studying the effects of TCDD on B cells. Nadine also held a Lab Assistant position at Kaiser Permanente Hospital, enhancing laboratory workflows, and participated as a CIRM Scholar and Researcher at CIRM Bridges to Stem Cell Research Internship, gaining expertise in neural stem/progenitor cell differentiation. Educational qualifications include a Doctor of Philosophy in Immunology and a Master's in Infectious Disease and Immunology, alongside a Bachelor's degree in Biology and an Associate degree in Biology.
Mozart Therapeutics
Mozart Therapeutics is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases. The company is using a novel regulatory CD8 T cell network to create disease-modifying CD8 Treg modulators for a variety of autoimmune diseases. Mozart is developing a pipeline of first-in-class 'CD8Treg modulators with the goal of restoring long-term immune balance and preventing the progressive damage caused by an autoreactive and pathogenic immune response.